InVivo Therapeutics

+$0.0002 (+0.03%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVIV and other ETFs, options, and stocks.

About NVIV

Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.

CEO
Richard Toselli
Employees
6
Headquarters
Cambridge, Massachusetts
Founded
2005

NVIV Key Statistics

Market Cap
22.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
656.76K
High Today
$0.68
Low Today
$0.6503
Open Price
$0.67
Volume
942.45K
52 Week High
$2.00
52 Week Low
$0.4975

NVIV Earnings

-$2.47
-$1.42
-$0.36
$0.69
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure